Heidelberg Pharma (ETR:HPHA) Will Have To Spend Its Cash Wisely
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
German (DAX) Biotech Industry Analysis
UpdatedJan 19, 2022
DataAggregated Company Financials
Companies14
- 7D-5.5%
- 3M-18.4%
- 1Y-41.0%
- YTD-8.6%
Over the last 7 days, the Biotech industry has dropped 5.5%, driven by a pullback from MorphoSys of 8.7%. Meanwhile, BioMark Diagnostics actually outperformed within the industry, gaining 11% in the last week. However, the industry is down 41% over the past year.
Industry Valuation and Performance
Has the German Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE |
|---|---|---|---|---|
| Thu, 20 Jan 2022 | €3.7b | €789.6m | -€311,283,353.00 | n/a |
| Sat, 18 Dec 2021 | €4.1b | €789.6m | -€311,690,565.00 | n/a |
| Mon, 15 Nov 2021 | €4.3b | €783.5m | -€247,037,521.00 | n/a |
| Wed, 13 Oct 2021 | €4.3b | €771.2m | -€257,628,521.00 | n/a |
| Fri, 10 Sep 2021 | €4.2b | €764.3m | -€161,273,228.00 | 1.3x |
| Sun, 08 Aug 2021 | €4.2b | €769.4m | -€175,243,228.00 | 1.4x |
| Sat, 01 May 2021 | €5.3b | €749.9m | -€236,050,839.00 | 1.1x |
| Tue, 02 Feb 2021 | €6.0b | €930.9m | -€76,599,954.23 | 33.1x |
| Fri, 06 Nov 2020 | €5.0b | €857.2m | -€136,640,199.02 | 55.3x |
| Mon, 10 Aug 2020 | €6.0b | €854.0m | -€122,928,578.95 | 33.5x |
| Sun, 03 May 2020 | €5.3b | €860.6m | -€123,838,236.32 | 20.5x |
| Wed, 05 Feb 2020 | €6.0b | €601.6m | -€402,351,766.74 | n/a |
| Sat, 09 Nov 2019 | €5.1b | €577.4m | -€195,098,305.00 | 282.9x |
| Fri, 02 Aug 2019 | €5.9b | €611.6m | -€326,492,610.76 | 39.3x |
| Mon, 06 May 2019 | €5.2b | €570.3m | -€160,055,631.00 | 115x |
| Thu, 07 Feb 2019 | €5.2b | €573.8m | -€164,563,263.00 | 37.4x |
PE Ratio
37.4x
Current Industry PE: There is insufficient data in this market to determine the PE ratio.
Past Earnings Growth: The earnings for companies in the Biotechs industry have deteriorated over the last three years, while revenues for these companies have grown 11% per year. This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Trends
Which industries have driven the changes within the German Biotech industry?
| Biotech | -5.54% | |
Industry PE: There is insufficient data on the sub-industries of this industry.
Forecasted Growth: Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 55% over the next 5 years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 20B BioMark Diagnostics | €0.14 | 10.9% +€1.1m | 48.7% | PE-12.6x |